Four drugs used in hospitals for years increased their prices between 525% and 1,644% after receiving formal approval through the Food and Drug Administration’s Unapproved Drug Initiative, according to an analysis released today by Vizient. 

Launched in 2006, the initiative requires drugs marketed before FDA began regulating drug safety and efficacy in 1938 to receive FDA approval to stay on the market. 

“Depending on the approval, manufacturers receive periods of exclusivity ranging from three to seven years,” said Dan Kistner, group senior vice president for pharmacy solutions at Vizient. “If a patent is awarded, the manufacturer could have market exclusivity for 20 years.” 

The study looks at four drugs approved through the UDI process since 2013, and estimates they will increase U.S. health care spending by $20.25 billion during their market exclusivity periods. With 19 additional drugs poised to go through this approval process, “the combined impact of the higher costs for these 23 drugs could be $29 billion,” Kistner said.
 

Related News Articles

Headline
Jon Ulven, Ph.D., behavioral health psychologist and chair of adult psychology at Sanford Health, details the fragile behavioral health landscape in rural…
Headline
The Senate narrowly passed the One Big Beautiful Bill Act (H.R. 1) on July 1 by a 50-50 tally, with Vice President J.D. Vance casting the tie-breaking vote.…
Headline
The AHA June 29 sent a letter to senators urging them to amend the budget reconciliation bill before its final passage in the Senate. The Senate version of the…
Headline
The latest video in the AHA’s series “Medicaid: Real Lives, Real Care” features Melissa Fannon-Wisner, DNP, nurse educator and nurse practitioner at Valley…
Headline
In a Q&A, Becky Pletzer, a social worker and mother, explains how critical Medicaid has been to support her son with disabilities, and why cuts to the…
Headline
The Supreme Court June 27 voted 6-3 to uphold an Affordable Care Act provision creating an independent task force charged with making recommendations of…